Dr Napolitano currently works at Montefiore Medical center, one of the busiest Emergency Departments in the country and a teaching affiliate of the Albert Einstein College of Medicine. He returns to this position after a one year period where he served as the Director of Clinical Operations at Nassau University Medical Center. Before assuming his position at the Albert Einstein College of Medicine he was an Attending Physician and Assistant Clinical Professor for Yale New Haven Health System at Bridgeport Hospital. He is boarded in both Internal and Emergency Medicine through residency training at the North Shore LIJ Combined Emergency Medicine/Internal Medicine Residency Program. He has been a practicing ED attending for 13years.

9174993098@txt.att.net (cell)
6469960460@messaging.sprintpcs.com
anapolit@montefiore.org

Acute Glomerulonephritis. In: GEMSoft [electronic media]. Lin M, Fraser G,
et al (eds). GEMSoft (General Emegency Medicine Software). Queensland, Australia: Pemsoft Pty Ltd. In press, 2012.

Rosen & Barkin's 5-Minute Emergency Medicine Consult 2010 Edition  

Edited by Jeffrey J. Schaider, Roger M. Barkin, Stephen R. Hayden, Richard E. Wolfe, Adam Z. Barkin, Philip Shayne, Peter Rosen

Authored Chapter on the approach to evaluating and managing Jaundice

Two milligrams IV hydromorphone is efficacious for treating pain but is associated with oxygen desaturation. Journal of Opiod Management. March/April 2009

Andrew K. Chang, MD, MS, Polly E. Bijur, PhD, Antonio Napolitano, MD, Jason

Lupow, MD, E. John Gallagher, MD

Symptomatic Hypotension: ED Stabilization And The Emerging Role Of Sonography EM Practice Nov 2007 Issue

AJ Weekes MD RDCS RDMS FAAEM, A Napolitano MD

FACEP, RJ Zapata MD

Case Report: Chronic appendicitis diagnosed in a patient presenting to the

Emergency Department with Reactive Arthritis.

Antonio Napolitano MD

FACEP, Fred Kimura MD (pending publication)

A Study of Avelox for Treatment of Elderly Patients with Community Acquired

Pneumonia

Sponsor : Bayer Corporation

A Comparison of the Efficacy and Safety of Tramadol HCl/Acetaminophen

Versus Hydrocodone Bitartrate/Acetaminophen Versus Placebo in

Subjects with Acute Musculoskeletal Pain

Sponsor : Ortho-McNeil

A Multicenter, Randomized, Double Blind, Comparative Trial of Intravenous

Merrem™ (meropenem) versus Primaxin® I.V. (imipenem-cilastin) in the

treatment of hospitalized patients with complicated skin and skin structure

infections.

Sponsor : Astra Zeneca Pharmaceuticals

Date : 2002 – 2003

Prospective, Uncontrolled, Open-Label, Multicenter Clinical Trial Evaluating the

Efficacy and Safety of Faropenem Daloxate 300 mg PO BID for 10 Days

in the Treatment of Patients with Community Acquired Pneumonia

Date : 2001 – 2002

Prospective, Randomized, Open-Label, Multicenter Comparison of the Efficacy

and Safety of Sequential Treatment with Intravenous (IV)/Oral (PO)

Moxifloxacin 400/400 mg Versus Ceftriaxone 2 gm IV +/-  IV/PO

Azithromycin +/-  IV/PO Metronidazole; followed by Cefuroxime axetil PO +/-

PO Azithromycin +/- PO Metronidazole in Patients with Community or

Nursing Home Acquired Pneumonia

Sponsor : Bayer Corporation

Date : 2001 – 2002

A prospective, randomized, double blind multicenter trial assessing the safety

and efficacy of sequential (intravenous/oral) BAY 12-8039 (moxifloxacin)

400 mg every 24 hours compared to intravenous piperacillin/tazobactam

3.375 grams every 6 hours followed by oral amoxicillin/clavulanic acid

suspension 800 mg every 12 hours for the treatment of patients with

complicated skin and skin structure infections.

Sponsor : Bayer Pharmaceutical

Date : 2000 - 2002